Jamieson Wellness Inc. Reports Third Quarter 2026 Results

Monday at 6:32pm AST · November 16, 2026 14 min read

TORONTO, Nov. 16, 2026 /CNW/ — Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its third quarter results for the period ended September 30, 2026. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See “Non-IFRS and Other Financial Measures” below.

Jamieson Wellness

Year-to-Date (9 Months Ended September 30, 2026) Financial Results Consolidated Summary 

All comparisons are with year-to-date (9 months ended September 30, 2025)

  • Consolidated revenue increased by 11.6% to $607.3 million, driven by 11.6% growth in Jamieson Brands, and 11.1% growth in Strategic Partners
  • Adjusted EBITDA2 increased by $8.2 million or 8.9% to $100.4 million
  • Net earnings were $35.5 million; Adjusted net earnings2 increased 10.8% to $45.3 million
  • Diluted earnings per share was $0.77; Adjusted diluted earnings per share3 was $1.05

Third Quarter Financial Results Consolidated Summary

All comparisons are with the third quarter of 2025

  • Consolidated revenue increased by $4.4 million to $203.7 million
    • Growth of 1.9% in Jamieson Brands revenue driven by strong growth in China, partially offset by shipments realized in the previous quarter in conjunction with our distribution centre transition, and timing impact of year over year innovations in Canada and the U.S.
    • 5.3% growth in Strategic Partners revenue led by customer ordering patterns and new programs with key customers.
  • Gross profit increased by $2.4 million to $86.0 million and gross profit margin1 increased by 30 basis points to 42.2%
  • Normalized gross profit margin1 increased by 280 basis points, mainly driven by higher revenue and geographic mix in the Jamieson Brands segment, partially offset by temporarily increased logistics costs due to rising oil costs
  • EBITDA2 decreased by $11.8 million to $21.3 million, mainly driven by specified costs and performance marketing, partially offset by higher revenue and gross profit; Adjusted EBITDA2 increased by $0.5 million or 1.4% to $38.5 million, driven primarily by higher gross profit in the Jamieson Brands segment
  • Net earnings were $7.3 million; Adjusted net earnings2 were $18.0 million, or $0.3 million higher, driven by lower interest expense and normalized tax expense, partially offset by lower normalized earnings from operations
  • Diluted earnings per share was $0.15; Adjusted diluted earnings per share3 was $0.42

1 This is a supplementary financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each supplementary financial measure.

2 This is a non-IFRS financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS financial measure.

3 This is a non-IFRS ratio. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS ratio.

Consolidated Financial Statements and Management’s Discussion and Analysis

The Company’s unaudited condensed consolidated interim financial statements and accompanying notes as at and for the three and nine months ended September 30, 2026 and related management’s discussion and analysis (“MD&A”) are available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Investor Relations section of the Company’s website at https://investors.jamiesonwellness.com.

Planned Acquisition by Kirin

On August 6, 2026, the Company entered into a definitive arrangement agreement (the “Arrangement Agreement”) with Kirin Holdings Company, Limited (“Kirin”), pursuant to which Kirin has agreed to acquire all of the issued and outstanding common shares of the Company (the “Common Shares”) (the “Transaction”) at a price of CAD $45.75 per Common Share in cash. At the Company’s special meeting of shareholders held on September 30, 2026, holders of Common Shares voted in favour of the special resolution approving the plan of arrangement and, on October 5, 2026, the Ontario Superior Court of Justice (Commercial List) issued a final order approving the plan of arrangement. Completion of the Transaction is currently expected to occur in the fourth quarter of 2026, subject to receipt of required regulatory clearances and approvals and the satisfaction or waiver of other customary closing conditions. It is expected that the Common Shares will be delisted from the Toronto Stock Exchange and that the Company will cease to be a reporting issuer in all applicable Canadian jurisdictions shortly thereafter. In connection with the announcement of the Arrangement Agreement, the Company withdrew its previously issued financial guidance for the 2026 fiscal year. For additional details regarding the Transaction, see the Company’s management information circular dated August 27, 2026, which is available on SEDAR+ at www.sedarplus.ca.

Conference Call

In light of the recently announced Transaction with Kirin Holdings, the Company will not be holding a third quarter 2026 results conference call.

About Jamieson Wellness  

Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada’s #1 vitamins, minerals and supplements (“VMS”) brand. The Company’s youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in approximately 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information, please visit jamiesonwellness.com.

Jamieson Wellness’ head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada.

Forward-Looking Information

This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to the Company’s anticipated results and statements regarding the Transaction, including the expected timing of completion of the Transaction, the receipt of required regulatory clearances and approvals, and the delisting of the Common Shares and the Company ceasing to be a reporting issuer. Words such as “expect”, “anticipate”, “intend”, “may”, “will”, “estimate” and variations of such words and similar expressions are intended to identify such forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances, which could prove to be incorrect.

The forward-looking information in this press release is based on a number of assumptions, including assumptions regarding the receipt, in a timely manner and on satisfactory terms, of required regulatory clearances and approvals; the satisfaction of the other conditions to completion of the Transaction; our ability to complete the Transaction on the terms and conditions contemplated, or on the timing currently contemplated; and general economic and market conditions.  The forward-looking information in this press release is also subject to a number of risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include the failure to obtain required regulatory clearances and approvals or to satisfy the other conditions to completion of the Transaction, delays in completing the Transaction, the termination of the Arrangement Agreement in certain circumstances, including the potential payment of a termination fee, and the effect of the announcement or pendency of the Transaction on our business, as well as the factors discussed under “Risk Factors” in the Company’s Annual Information Form dated March 31, 2026 and under the “Risk Factors” section in the Company’s MD&A for the three and nine months ended September 30, 2026. The Company cautions that the foregoing list of assumptions and risks is not exhaustive and other factors could also adversely affect the Company’s results.

The forward-looking information in this press release is given as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Jamieson Wellness Inc.

Selected Consolidated Financial Information

In thousands of Canadian dollars, except share and per share amounts


Three months ended


 Nine months ended 


September 30


 September 30 


2026


2025


2026


2025









Revenue

203,732


199,325


607,326


544,397

Cost of sales

117,684


115,710


354,801


324,748

Gross profit

86,048


83,615


252,525


219,649









Gross profit margin

42.2 %


41.9 %


41.6 %


40.3 %









Selling, general and administrative expenses

67,408


52,341


185,513


157,274

Share-based compensation

2,229


2,118


6,824


6,283

Earnings from operations

16,411


29,156


60,188


56,092









Operating margin

8.1 %


14.6 %


9.9 %


10.3 %









Foreign exchange loss/(gain)

632


935


(3,992)


(310)

Interest expense and other financing costs

6,018


6,329


18,638


16,008

Accretion on preferred shares

–


–


–


3,427

Earnings before income taxes

9,761


21,892


45,542


36,967

Provision for income taxes

2,473


6,379


10,044


10,140

Net earnings

7,288


15,513


35,498


26,827









Net earnings attributable to:








Shareholders

6,283


14,979


33,040


25,604

Non-controlling interests

1,005


534


2,458


1,223


7,288


15,513


35,498


26,827

Adjusted net earnings

17,974


17,679


45,315


40,894









EBITDA 

21,255


33,095


80,077


71,010

Adjusted EBITDA

38,511


37,969


100,364


92,135

Adjusted EBITDA margin

18.9 %


19.0 %


16.5 %


16.9 %









Weighted average number of shares








Basic

41,499,492


41,819,276


41,455,268


41,836,515

Diluted

43,053,161


43,091,108


42,953,706


43,044,430









Earnings per share attributable to common shareholders:








Basic, earnings per share

0.15


0.36


0.80


0.61

Diluted, earnings per share

0.15


0.35


0.77


0.59

Adjusted diluted, earnings per share

0.42


0.41


1.05


0.95

 

Jamieson Wellness Inc.

Consolidated Statements of Financial Position

In thousands of Canadian dollars


September 30,

2026


December 31,

2025

Assets




Current assets




Cash

41,068


41,225

Accounts receivable

147,534


199,245

Inventories

273,977


203,083

Derivatives

941


486

Prepaid expenses and other current assets                                                    

12,871


7,303

Income taxes recoverable

7,567


–


483,958


451,342

Non-current assets




Property, plant and equipment

115,961


117,342

Goodwill

285,303


279,644

Intangible assets

365,343


362,753

Deferred income tax

2,783


3,951

Total assets

1,253,348


1,215,032





Liabilities




Current liabilities




Accounts payable and accrued liabilities

128,459


155,266

Income taxes payable

1,385


2,894

Derivatives

2,302


3,971

Current portion of other long-term liabilities

5,733


12,014


137,879


174,145

Long-term liabilities




Long-term debt

465,000


414,597

Post-retirement benefits

1,374


1,282

Deferred income tax

69,356


68,855

Other long-term liabilities

24,128


26,642

Total liabilities

697,737


685,521





Equity




Share capital

340,845


333,347

Warrants

14,705


14,705

Contributed surplus

28,203


27,494

Retained earnings

94,011


90,374

Accumulated other comprehensive income

30,063


19,498

Total shareholders’ equity

507,827


485,418

Non-controlling interests

47,784


44,093

Total equity

555,611


529,511

Total liabilities and equity

1,253,348


1,215,032

Non-IFRS and Other Financial Measures

This press release makes reference to certain financial measures, including non-IFRS financial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and to analyze the Company’s business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company’s financial information reported under IFRS. The Company uses the following non-IFRS financial measures: “EBITDA”, “Adjusted EBITDA” and “Adjusted net earnings”, the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, “normalized gross profit”, “normalized SG&A”, “normalized earnings from operations”, “cash from operating activities before working capital considerations” and “net debt”, the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: “Adjusted EBITDA margin”, “Adjusted diluted earnings per share”, “normalized gross profit margin”, “normalized operating margin”, and the following supplementary financial measures: “gross profit margin” and “operating margin” to provide supplemental measures of the Company’s operating performance and thus highlight trends in the Company’s core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the “How we Assess the Performance of our Business” section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS financial measure to its most directly comparable financial measure disclosed in the Company’s financial statements to which the measure relates.

The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS financial measures (see the “Non-IFRS and Other Financial Measures” of this press release for further information on each non-IFRS financial measure) for the three and nine months ended September 30, 2026.

Jamieson Wellness Inc.

Segment Information

In thousands of Canadian dollars, except as otherwise noted

Jamieson Brands



















Three months ended

September 30







2026


2025


 $ Change 


% Change 











Revenue

183,927


180,523


3,404


1.9 %











Gross profit

83,799


81,253


2,546


3.1 %


Distribution centre transition (2)

4,925


–


4,925


100.0 %


Normalized gross profit

88,724


81,253


7,471


9.2 %











Gross profit margin

45.6 %


45.0 %


–


0.6 %


Normalized gross profit margin

48.2 %


45.0 %


–


3.2 %











Share-based compensation (1)

2,229


2,118


111


5.2 %











Selling, general and administrative expenses

65,954


50,815


15,139


29.8 %


Acquisition and divestiture related costs (6)

(8,133)


–


(8,133)


(100.0 %)


IT system implementation (3)

(970)


(1,363)


393


28.8 %


Legal and other (4)

(367)


(458)


91


19.9 %


Normalized selling, general and administrative expenses

56,484


48,994


7,490


15.3 %











Earnings from operations

15,616


28,320


(12,704)


(44.9 %)


Acquisition and divestiture related costs (6)

8,133


–


8,133


100.0 %


Distribution centre transition (2)

4,925


–


4,925


100.0 %


IT system implementation (3)

970


1,363


(393)


(28.8 %)


Legal and other (4)

367


458


(91)


(19.9 %)


Normalized earnings from operations

30,011


30,141


(130)


(0.4 %)











Operating margin

8.5 %


15.7 %


–


(7.2 %)


Normalized operating margin

16.3 %


16.7 %


–


(0.4 %)











Adjusted EBITDA

37,018


36,469


549


1.5 %


Adjusted EBITDA margin

20.1 %


20.2 %


–


(0.1 %)



















Strategic Partners



















Three months ended

September 30







2026


2025


 $ Change 


% Change 











Revenue

19,805


18,802


1,003


5.3 %


Gross profit

2,249


2,362


(113)


(4.8 %)











Gross profit margin

11.4 %


12.6 %


–


(1.2 %)











Selling, general and administrative expenses

1,454


1,526


(72)


(4.7 %)











Earnings from operations

795


836


(41)


(4.9 %)











Operating margin

4.0 %


4.4 %


–


(0.4 %)


Adjusted EBITDA

1,493


1,500


(7)


(0.5 %)


Adjusted EBITDA margin

7.5 %


8.0 %


–


(0.5 %)



















Jamieson Brands



















Nine months ended

September 30







2026


2025


$ Change


% Change 











Revenue

546,049


489,221


56,828


11.6 %











Gross profit

245,112


213,294


31,818


14.9 %


Distribution centre transition (2)

6,256


–


6,256


100.0 %


IT system implementation (3)

–


1,023


(1,023)


(100.0 %)


Normalized gross profit

251,368


214,317


37,051


17.3 %











Gross profit margin

44.9 %


43.6 %


–


1.3 %


Normalized gross profit margin

46.0 %


43.8 %


–


2.2 %











Share-based compensation (1)

6,824


6,283


541


8.6 %











Selling, general and administrative expenses

180,800


152,622


28,178


18.5 %


Acquisition and divestiture related costs (6)

(8,133)


–


(8,133)


(100.0 %)


IT system implementation (3)

(2,014)


(9,445)


7,431


78.7 %


Donations (5)

–


(3,118)


3,118


100.0 %


Legal and other (4)

(1,052)


(1,340)


288


21.5 %


Normalized selling, general and administrative expenses

169,601


138,719


30,882


22.3 %











Earnings from operations

57,488


54,389


3,099


5.7 %


Acquisition and divestiture related costs (6)

8,133


–


8,133


100.0 %


IT system implementation (3)

2,014


10,468


(8,454)


(80.8 %)


Distribution centre transition (2)

6,256


–


6,256


100.0 %


Donations (5)

–


3,118


(3,118)


(100.0 %)


Legal and other (4)

1,052


1,340


(288)


(21.5 %)


Normalized earnings from operations

74,943


69,315


5,628


8.1 %











Operating margin

10.5 %


11.1 %


–


(0.6 %)


Normalized operating margin

13.7 %


14.2 %


–


(0.5 %)











Adjusted EBITDA

95,581


88,197


7,384


8.4 %


Adjusted EBITDA margin

17.5 %


18.0 %


–


(0.5 %)



















Strategic Partners



















Nine months ended

September 30







2026


2025


 $ Change 


% Change 











Revenue

61,277


55,176


6,101


11.1 %











Gross profit

7,413


6,355


1,058


16.6 %


IT system implementation (3)

–


226


(226)


(100.0 %)


Normalized gross profit

7,413


6,581


832


12.6 %











Gross profit margin

12.1 %


11.5 %


–


0.6 %


Normalized gross profit margin

12.1 %


11.9 %


–


0.2 %











Selling, general and administrative expenses

4,713


4,652


61


1.3 %











Earnings from operations

2,700


1,703


997


58.5 %


IT system implementation (3)

–


226


(226)


(100.0 %)


Normalized earnings  from operations

2,700


1,929


771


40.0 %











Operating margin

4.4 %


3.1 %


–


1.3 %


Normalized operating margin

4.4 %


3.5 %


–


0.9 %











Adjusted EBITDA

4,783


3,938


845


21.5 %


Adjusted EBITDA margin

7.8 %


7.1 %


–


0.7 %

 

Reconciliation of Non-IFRS Financial Measures

In thousands of Canadian dollars


Three months ended


 Nine months ended 


 September 30 


 September 30 


2026


2025


2026


2025

















 Net earnings:

7,288


15,513


35,498


26,827

Add:








Provision for income taxes

2,473


6,379


10,044


10,140

Interest expense and other financing costs

6,018


6,329


18,638


16,008

Accretion on preferred shares

–


–


–


3,427

Depreciation of property, plant, and equipment

3,991


3,419


11,461


10,148

Amortization of intangible assets

1,485


1,455


4,436


4,460









Earnings before interest, taxes, depreciation, and amortization (EBITDA)

21,255


33,095


80,077


71,010

Share-based compensation (1)

2,229


2,118


6,824


6,283

Foreign exchange loss/(gain)

632


935


(3,992)


(310)

Acquisition and divestiture related costs (6)

8,133


–


8,133


–

Distribution centre transition (2)

4,925


–


6,256


–

IT system implementation (3)

970


1,363


2,014


10,694

Donations (5)

–


–


–


3,118

Legal and other (4)

367


458


1,052


1,340

Adjusted EBITDA

38,511


37,969


100,364


92,135









Provision for income taxes

(2,473)


(6,379)


(10,044)


(10,140)

Interest expense and other financing costs

(6,018)


(6,329)


(18,638)


(16,008)

Financing costs on renewal of credit facility 

–


–


2,173


–

Depreciation of property, plant, and equipment

(3,991)


(3,419)


(11,461)


(10,148)

Amortization of intangible assets

(1,485)


(1,455)


(4,436)


(4,460)

Share-based compensation (1)

(2,229)


(1,996)


(6,745)


(5,917)

Tax deduction from vesting of certain share-based awards

–


–


(2,002)


(708)

Tax effect of normalization adjustments

(4,341)


(712)


(3,896)


(3,860)

Adjusted net earnings

17,974


17,679


45,315


40,894


















Three months ended


 Nine months ended 


 September 30 


 September 30 


2026


2025


2026


2025









Gross profit

86,048


83,615


252,525


219,649

IT system implementation (3)

–


–


–


1,249

Distribution centre transition (2)

4,925


–


6,256


–

Normalized gross profit

90,973


83,615


258,781


220,898

Normalized gross profit margin

44.7 %


41.9 %


42.6 %


40.6 %









Selling, general and administrative expenses

67,408


52,341


185,513


157,274

Acquisition and divestiture related costs (6)

(8,133)


–


(8,133)


–

IT system implementation (3)

(970)


(1,363)


(2,014)


(9,445)

Donations (5)

–


–


–


(3,118)

Legal and other (4)

(367)


(458)


(1,052)


(1,340)

Normalized selling, general and administrative expenses

57,938


50,520


174,314


143,371









Earnings from operations

16,411


29,156


60,188


56,092

Acquisition and divestiture related costs (6)

8,133


–


8,133


–

Distribution centre transition (2)

4,925


–


6,256


–

Donations (5)

–


–


–


3,118

IT system implementation (3)

970


1,363


2,014


10,694

Legal and other (4)

367


458


1,052


1,340

Normalized earnings from operations

30,806


30,977


77,643


71,244

Normalized operating margin

15.1 %


15.5 %


12.8 %


13.1 %



(1)

Our share-based compensation expense pertains to our LTIP (refer to “Share-based compensation”), with stock option, PSU, RSU and DSU expenses, along with associated payroll taxes.



(2)

Includes costs related to the transition of our existing distribution centre to a larger and more efficient facility.



(3)

Current year mainly pertains to IT system development and enhancement costs. Prior year includes development costs associated with our IT system implementation to augment our system infrastructure. Unlike other system improvement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly.



(4)

Includes professional service fees relating to completed due diligence costs for an unsuccessful acquisition in 2025 and other non-recurring expenses primarily relating to non-operational legal costs.



(5)

Includes cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildfires in 2025.



(6)

On August 6, 2026, the Company entered into the Arrangement Agreement with Kirin following the receipt of an unsolicited acquisition proposal from another party, a strategic sales process, and extensive negotiations regarding the Transaction. These costs include legal, financial advisory, consulting and other professional fees incurred in connection with the sales process, execution of the Transaction, and related sale-preparation activities undertaken by the Company.

 

Reconciliation of Net Debt 

In thousands of Canadian dollars

($ in 000’s)

As at September 30,


As at December 31,


2026


2025





Long-term debt                                                                                  

465,000


414,597

Cash

(41,068)


(41,225)

Net debt 

423,932


373,372

SOURCE Jamieson Wellness Inc.

displaying rededs